Results 31 to 40 of about 173,434 (149)
Clinical Application for Tissue Engineering Focused on Materials
Cardiovascular-related medical conditions remain a significant cause of death worldwide despite the advent of tissue engineering research more than half a century ago.
Takahiro Kitsuka +5 more
doaj +1 more source
Tissue engineering of vascular conduits
AbstractBackgroundAutologous conduits are not available in up to 40 per cent of patients with arteriopathy who require coronary or lower limb revascularization, and access sites for renal dialysis may eventually become exhausted. Synthetic prostheses achieve a poor patency rate in small-calibre anastomoses.
K-H, Yow +4 more
openaire +2 more sources
Using Polymeric Scaffolds for Vascular Tissue Engineering
With the high occurrence of cardiovascular disease and increasing numbers of patients requiring vascular access, there is a significant need for small-diameter (
Alida Abruzzo +10 more
doaj +1 more source
By synthesizing new polymeric materials and combining them with growth factors or cells, new tissues and organs can potentially be created for use in drug testing-thereby potentially reducing animal and human testing- and to treat disease.
Robert Langer
doaj +1 more source
Small-diameter tissue-engineered vascular grafts (sdTEVGs) with hyperglycemia resistance have not been constructed. The intimal hyperplasia caused by hyperglycemia remains problem to hinder the patency of sdTEVGs.
Yanzhao Li +19 more
doaj +1 more source
Background Adipose tissue-derived microvascular fragments are functional vessel segments derived from arterioles, capillaries, and veins. Microvascular fragments can be used as vascularization units in regenerative medicine and tissue engineering ...
Gyu Tae Park +11 more
doaj +1 more source
Novel Approach by Nanobiomaterials in Vascular Tissue Engineering
Interactions between vascular endothelial cells (ECs) and biomaterials are important for engineered tissue substitute. The modification of biomaterial surfaces are designed to modulate EC adhesion and responses in order to improve implantation success ...
Huey-Shan Hung +3 more
doaj +1 more source
Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts
The treatment of patients with severe coronary and peripheral artery disease represents a significant clinical need, especially for those patients that require a bypass graft and do not have viable veins for autologous grafting.
Kenyatta S. Washington, Chris A. Bashur
doaj +1 more source
Three-dimensional silk fibroin microsphere-nanofiber scaffolds for vascular tissue engineering
A significant limitation in the engineering of artificial small-diameter vascular scaffolds is that the number of endothelial cells (ECs) is not sufficient to generate a confluent coverage of the vascular scaffolds, so that the surfaces of vascular ...
Qiang Liu +7 more
doaj +1 more source
Engineering Spatiotemporal Control in Vascularized Tissues
A major challenge in engineering scalable three-dimensional tissues is the generation of a functional and developed microvascular network for adequate perfusion of oxygen and growth factors. Current biological approaches to creating vascularized tissues include the use of vascular cells, soluble factors, and instructive biomaterials.
Astha Khanna +2 more
openaire +3 more sources

